MedTrace Logo

Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora

NCT00312338 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 137

Last updated 2012-11-02

Study results available
· View outcomes & findings →

Summary

Topical Treatment of Bacterial Conjunctivitis and its Effect on Microbial Flora

Conditions

  • Bacterial Conjunctivitis

Interventions

DRUG

VIGAMOX

1 drop of VIGAMOX® ophthalmic solution 0.5% in both eyes TID for 7 days

Sponsors & Collaborators

  • Tufts University

    collaborator OTHER

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Steven J. Lichtenstein, M.D. · Investigator / Contact

Study Design

Allocation
NON_RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2007-06-30
Completion
2007-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00312338 on ClinicalTrials.gov